Richard L. Boyd

19 Innovation Walk
Clayton, VIC 3800, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 52 publications

CAR-NK Engineering to Overcome TME Barriers.

CAR-NK Engineering to Overcome TME Barriers.

Journal: Cells

Published: October 29, 2025

Engineering TAG-72 and CD30 CAR-T Cells for T Cell Malignancies.

Engineering TAG-72 and CD30 CAR-T Cells for T Cell Malignancies.

Journal: Immunological investigations

Published: August 01, 2025

CRISPR-Cas9 knockout of DGKα/ζ improves the anti-tumor activities of TAG-72 CAR-T cells in ovarian cancer.

CRISPR-Cas9 knockout of DGKα/ζ improves the anti-tumor activities of TAG-72 CAR-T cells in ovarian cancer.

Journal: Molecular therapy. Oncology

Published: August 30, 2024

Targeting TAG-72 in cutaneous T cell lymphoma.

Targeting TAG-72 in cutaneous T cell lymphoma.

Journal: Heliyon

Published: March 03, 2024

Engineering T cell receptor fusion proteins using nonviral CRISPR/Cas9 genome editing for cancer immunotherapy.

Engineering T cell receptor fusion proteins using nonviral CRISPR/Cas9 genome editing for cancer immunotherapy.

Journal: Bioengineering & translational medicine

Published: January 09, 2023

Fibroblastic reticular cells provide a supportive niche for lymph node-resident macrophages.

Fibroblastic reticular cells provide a supportive niche for lymph node-resident macrophages.

Journal: European journal of immunology

Published: December 23, 2022

CAR-T cell development for Cutaneous T cell Lymphoma: current limitations and potential treatment strategies.

CAR-T cell development for Cutaneous T cell Lymphoma: current limitations and potential treatment strategies.

Journal: Frontiers in immunology

Published: June 13, 2022

Micro-hydrogel injectables that deliver effective CAR-T immunotherapy against 3D solid tumor spheroids.

Micro-hydrogel injectables that deliver effective CAR-T immunotherapy against 3D solid tumor spheroids.

Journal: Translational oncology

Published: April 02, 2022

Integrin-Linked Kinase Expression Characterizes the Immunosuppressive Tumor Microenvironment in Colorectal Cancer and Regulates PD-L1 Expression and Immune Cell Cytotoxicity.

Integrin-Linked Kinase Expression Characterizes the Immunosuppressive Tumor Microenvironment in Colorectal Cancer and Regulates PD-L1 Expression and Immune Cell Cytotoxicity.

Journal: Frontiers in oncology

Published: December 15, 2021

Low-dose mesenchymal stem cell therapy for discogenic pain: safety and efficacy results from a 1-year feasibility study.

Low-dose mesenchymal stem cell therapy for discogenic pain: safety and efficacy results from a 1-year feasibility study.

Journal: Future science OA

Published: December 05, 2021

'Off-the-Shelf' Immunotherapy: Manufacture of CD8+ T Cells Derived from Hematopoietic Stem Cells.

'Off-the-Shelf' Immunotherapy: Manufacture of CD8+ T Cells Derived from Hematopoietic Stem Cells.

Journal: Cells

Published: July 23, 2021

Enhancing a Natural Killer: Modification of NK Cells for Cancer Immunotherapy.

Enhancing a Natural Killer: Modification of NK Cells for Cancer Immunotherapy.

Journal: Cells

Published: April 01, 2021

Showing 1-12 of 52

Last Updated: 09/26/2026